A pragmatic randomised controlled trial comparing the effectiveness and cost effectiveness of levetiracetam and zonisamide versus standard treatments for epilepsy: a comparison of Standard And New Antiepileptic Drugs (SANAD-II)
Phase of Trial: Phase IV
Latest Information Update: 02 Feb 2018
At a glance
- Drugs Levetiracetam (Primary) ; Zonisamide (Primary) ; Lamotrigine; Valproic acid
- Indications Epilepsy
- Focus Therapeutic Use
- Acronyms SANAD-II
- 13 Jul 2016 Status changed from recruiting to completed.
- 04 Nov 2015 Accrual to date is 69% according to the United Kingdom Clinical Research Network record.
- 04 Oct 2015 Accrual to date is 66% according to the United Kingdom Clinical Research Network record.